Side Effects of CXC-Chemokine Receptor 4–Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation

The chemokine receptor CXC-chemokine receptor 4 (CXCR4) is a transmembrane receptor involved in survival, proliferation, and dissemination of different cancers, including hematopoietic malignancies. Relapsed or refractory hematopoietic cancers are frequently resistant to conventional therapy, and no...

詳細記述

保存先:
書誌詳細
出版年:J Nucl Med
主要な著者: Maurer, Sabine, Herhaus, Peter, Lippenmeyer, Romina, Hänscheid, Heribert, Kircher, Malte, Schirbel, Andreas, Maurer, H. Carlo, Buck, Andreas K., Wester, Hans-Jürgen, Einsele, Hermann, Grigoleit, Götz-Ulrich, Keller, Ulrich, Lapa, Constantin
フォーマット: Artigo
言語:Inglês
出版事項: Society of Nuclear Medicine 2019
主題:
Theranostics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785788/
https://ncbi.nlm.nih.gov/pubmed/30850502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.223420
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料